.. Table I. Treatment guidelines for patients with seasonal affective disorder. Adapted from ref 9: Lewy AJ. Treating chronobiologic sleep and mood disorders with bright light. Psychiatric Annals, 1987; 17:664-669. Copyright © Charles Slack 1987. The dim light melatonin onset The dim light melatonin onset (DLMO) Is now the most commonly used marker for circadian phase position in humans.11 Either plasma or saliva is collected usually every 30 minutes between 6 PM and bedtime.12,13 The current recommendation for dim light is light that is too dim to allow reading without a book-light pointed directed at the page. Dim

light should begin at about 5 PM. The DLMO can be operationally defined as Inhibitors,research,lifescience,medical the interpolated time when melatonin levels continuously rise above 10 pg/mL in plasma or Inhibitors,research,lifescience,medical 3 pg/mL in saliva. In some cases, Sotrastaurin thresholds of 2 pg/mL in plasma and 0.7 pg/mL in saliva are used; melatonin usually reaches these thresholds about 1hour earlier than the 10 pg/mL (3 pg/mL) thresholds (Figure 2). The DLMO appears to be a better marker for circadian phase position than core body temperature,

even when the latter is measured in a constant routine.11 Furthermore, posture, sleep, activity, and meals do not need to be controlled when using the DLMO as a marker for phase position of the endogenous circadian pacemaker. Salivary DLMOs obtained in the home may soon become a standard procedure for the clinician. Space constraints do not permit a critical review of the Inhibitors,research,lifescience,medical literature

in which the DLMO was initially considered to be the marker of just one component of a complex circadian oscillator.14-17 Figure 2. The dim light melatonin onset (DLMO) in plasma is operationally defined as the interpolated time when melatonin levels continuously rise above the threshold of either 10 Inhibitors,research,lifescience,medical pg/mL or 2 pg/mL (which usually occurs about 1hour earlier). In this figure the DLMO … Testing the PSH using melatonin administration In order to provide a critical and falsifiable test of the PSH, we Inhibitors,research,lifescience,medical administered melatonin to cause phase shifts and thus avoided the large placebo component that accompanies light treatment. According to the melatonin PRC,18,19 melatonin administered in the morning (AM) causes a phase delay, and melatonin administered in the afternoon/evening (PM) causes a phase advance. That is, the melatonin PRC is about 12 hours out of phase with the light PRC. Rolziracetam Therefore, according to the PSH, most SAD patients should preferentially respond to PM melatonin. After a baseline week in which subjects were permitted to sleep only between consistent bedtimes and wake times of their choosing and a baseline DLMO assessment, subjects were assigned to one of three regimens (AM melatonin, PM melatonin, or placebo capsules only). The melatonin dose varied slightly according to the year and was divided into 3 to 4 capsules, 2 hours apart; the total dose was 0.225 to 0.3 mg per day, depending on the year.20 Patients took 7 to 8 capsules per day, depending on the year.